Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Vertex Pharmaceuticals (Sweden) AB

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 44,629 Less Arrow 39,120 Less Arrow 34,490
Financial expenses 1 More Arrow 223 Less Arrow 76
Earnings before taxes 3,187 Less Arrow 2,574 Less Arrow 2,310
EBITDA 3,238 Less Arrow 3,096 Less Arrow 2,398
Total assets 23,660 Less Arrow 21,903 More Arrow 43,796
Current assets 23,610 Less Arrow 21,723 More Arrow 43,269
Current liabilities 10,589 More Arrow 10,915 More Arrow 34,751
Equity capital 13,071 Less Arrow 10,989 Less Arrow 9,045
- share capital 32 More Arrow 34 Less Arrow 33
Employees (average) 11 Less Arrow 9 Less Arrow 7

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 55.2% Less Arrow 50.2% Less Arrow 20.7%
Turnover per employee 4,057 More Arrow 4,347 More Arrow 4,927
Profit as a percentage of turnover 7.1% Less Arrow 6.6% More Arrow 6.7%
Return on assets (ROA) 13.5% Less Arrow 12.8% Less Arrow 5.4%
Current ratio 223.0% Less Arrow 199.0% Less Arrow 124.5%
Return on equity (ROE) 24.4% Less Arrow 23.4% More Arrow 25.5%
Change turnover 6,803 Less Arrow 4,452 Less Arrow 4,338
Change turnover % 18% Less Arrow 13% More Arrow 14%
Chg. No. of employees 2 Equal arrow 2 Less Arrow 0
Chg. No. of employees % 22% More Arrow 29% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.